Joe Toniolo
Senior Director, Health & Welfare Plans, US Foods
“Virta is a life-changing solution your team will thank you for”
From obesity, to prediabetes and type 2 diabetes, Virta can help your population reverse their diagnosis and take back their lives.
Reset the standard for metabolic care
Virta delivers unmatched outcomes for our members—helping people reverse type 2 diabetes and prediabetes, and achieve sustainable weight loss. Our personalized, continuous, and virtual care approach accounts for your population’s unique needs and preferences, and makes results last.
Sustainable Weight Loss
Deliver clinically significant weight loss and prediabetes support without medications
Responsible Prescribing for GLP-1s
Weight loss GLP-1s + personalized nutrition and lifestyle support with guardrails to optimize spend
Diabetes Reversal
Safely deprescribe diabetes medications and return blood sugar to subdiabetic levels
Diabetes Management
Monitor and control blood sugar, provide app-based educational content, and a path to reversal
Transformative outcomes that last
Our members experience results quickly, often in a matter of weeks, and results last.
Average Weight Loss
13%
Our members experience weight loss similar to that delivered by current weight-loss drugs¹
Sustained Weight Loss After GLP-1
85%
Sustained weight loss a year after GLP-1 deprescription²
Cost Savings
$6,000
Reversing metabolic conditions leads to massive savings—$6k per enrolled member per year³
Industry-leading sustainable weight loss
Virta offers a better way to navigate obesity and Rx costs and utilization for both weight loss and type 2 diabetes. With a decade of nutrition focused care with and without GLP-1s, Virta is the only partner with peer-reviewed results showing sustained weight loss a year after GLP-1s have been deprescribed.
Case Studies
Reversal is life-changing. Our members say it best.
Linda lost 65 pounds and celebrated new victories
“For decades, I had tried everything to lose weight. Bariatric surgery was next—I had even signed up for the procedure. Then I found out about Virta. Since then, I’ve lost 65 pounds, while reducing my medications. I can finally fit comfortably behind the steering wheel in my car and put the tray table down on an airplane. It feels like a miracle.”
Dan is thriving after seeing results he didn't think were possible
“I lost 30 pounds on Ozempic, yet I still couldn’t get my blood sugar under control. And I hated the injections. Since starting Virta, I’ve lost 110 pounds and reversed my diabetes, while eliminating Ozempic and several other diabetes medications. Plus, I’m walking 8-10 miles per day. These are results like I’ve never seen before, and never thought I would.”
Sheila reversed her condition and regained her energy
“I’m half Puero Rican, half Barbadian, and diabetes has run rampant in my family and my community for generations—resulting in amputations and even death for several of my closest family members. Through Virta, I’ve now reversed my diabetes, lost over 20 pounds, and regained my energy. The diabetes epidemic in my family stops with me.”
The Reversal Advantage
Only reversal offers a non-invasive, cost effective, and sustainable way to improve metabolic health for your population¹,⁴
Pay for results, not promises
Virta only gets paid if we are successful in delivering real health improvement—the way all payment should work in healthcare.
100% fees at risk for:
- A1c improvements
- Weight loss with or without GLP-1s
- Prescription reductions
- 0% GLP-1 utilization trend*
We don't charge for:
- Implementation
- Non-participants
- Engagement
* Virta's performance guarantees are based on program design and do not inappropriately influence provider clinical decision-making. All medication decisions are made by healthcare providers using independent clinical judgment based on individual member needs. Member health and safety remain the primary consideration in all clinical decisions.
Transform your organization’s approach to diabetes care and weight loss
We partner with forward-thinking employers and health plans to create a new standard of metabolic care in their organizations.
Contact us
Ready to help your population reverse obesity and type 2 diabetes while managing Rx and medical spend?
Let's talkCitations and Footnotes
- McKenzie AL, Athinarayanan SJ, McCue JJ, Adams RN, Keyes M, McCarter JP, Volek JS, Phinney SD, Hallberg SJ. Type 2 Diabetes Prevention Focused on Normalization of Glycemia: A Two-Year Pilot Study. Nutrients. 2021 Feb 26;13(3):749.
- McKenzie, A.L., Athinarayanan, S.J. Impact of Glucagon-Like Peptide 1 Agonist Deprescription in Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study. Diabetes Ther (2024). https://doi.org/10.1007/s13300-024-01547-0
- Virta Health actuarial analysis based on clinical trial results, published in 2021. Trended 2 years using 6.5% for Medical and 8.8% for Rx. Savings model available upon request.
- Livongo Health, Empowering People with Chronic Conditions, September 2018